Company / Profit Margin
Perspective Therapeutics, Inc. Profit Margin History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-249.9%
FY2022
5-year range
-394.5% / -98.8%
FY2018-FY2022
Trend
-15.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -394.5% in FY2019 to -68.8% in FY2013.
Based on SEC 10-K filings.
-249.9% in FY2022 with a 5-year CAGR of -170.0%.
Improved from -289.4% to -249.9% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +144.6pp
- 5-Year Change
- -170.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, profit margin decreased 15.8% year-over-year.
- Peak profit margin was recorded in FY2013.
- Lowest profit margin in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -249.9% | -15.8% |
| FY2021 | -215.8% | +25.4% |
| FY2020 | -289.4% | +26.6% |
| FY2019 | -394.5% | -299.4% |
| FY2018 | -98.8% | -23.6% |
| FY2017 | -79.9% | +43.4% |
| FY2016 | -141.2% | -65.7% |
| FY2015 | -85.2% | +0.0% |
| FY2014 | -85.2% | -23.9% |
| FY2013 | -68.8% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026